Marijuana for Parkinson’s Disease?

Canna Clinical TrialsLeave a comment

Marijuana is popular in the United States and is being widely legalized for recreational and medicinal purposes. It remains a Schedule 1 substance without fully proven risks and benefits; yet, it is increasingly available in many US states and territories. Cannabis might have medicinal efficacy in Parkinson’s disease as a form of medical marijuana. Endocannabinoid receptors exist throughout the nervous system and are documented to influence receptors affecting a wide variety of areas. Neuroprotective aspects might be induced by cannabis exposure that might yield benefit against the nigrostriatal degeneration of patients with Parkinson’s disease.

[Cannabis in Parkinson’s Disease: Hype or help?]

Canna Clinical TrialsLeave a comment

Cannabis buds and extracts as well as synthetic cannabinoids have been available on prescription to patients with severe diseases since March 2017, with the costs covered by health insurance companies.The prescription of medical marihuana is not restricted to specific symptoms and is therefore also valid for patients with Parkinson’s disease. Furthermore, the authors state their opinion on which indications cannabinoids could be useful in treating patients with Parkinson’s disease or in which situation the patient could or even should be prescribed cannabinoids.